Studies by Shimoyama et al. show that the applicability of PG combined with anti-Hp IgG needs further verification when performing GC screening in areas with a high infection rate of Hp and in elderly populations with a high prevalence rate of atrophic gastritis [9]. This evidence concerns the gene HP and infection.